| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | AVALANCHE BIOTECHNOLOGIES IN | 37,400 | 1,515,000 | 0.11% | ||
| 102 | LOXO ONCOLOGY INC COM | 114,600 | 1,427,000 | 0.11% | ||
| 103 | PACIRA PHARMACEUTICALS INC | 13,300 | 1,182,000 | 0.09% | ||
| 104 | FEI COMPANY | 14,800 | 1,130,000 | 0.09% | ||
| 105 | MEDIDATA SOLUTIONS INC | 18,900 | 927,000 | 0.07% | ||
| 106 | TELEFLEX INC | 5,800 | 701,000 | 0.05% | ||
| 107 | XOMA CORP DEL | 177,200 | 645,000 | 0.05% | ||
| 108 | RAPTOR PHARMACEUTICAL CORP | 30,000 | 326,000 | 0.02% | ||
| 109 | VERASTEM INC | 20,900 | 213,000 | 0.02% | ||
| 110 | Codexis Inc Com | 10,000 | 46,000 | 0.00% | ||
| 111 | ZAFGEN INC COM | 600 | 24,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001442891-15-000004, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
